Prof. Dr. Anette-Gabriele ZieglerDirector of the Institute of Diabetes Research at Helmholtz Munich, German Research Center for Environmental Health
Scientific Career & Research Areas
Anette-Gabriele Ziegler studied medicine in Munich, Germany. After working as a physician in Munich, Klinikum Schwabing, she received postdoctoral training at the Joslin Diabetes Center and the Harvard Medical School. In 1989 she returned to the Klinikum Schwabing Munich, and started her independent laboratory at the Forschergruppe Diabetes e. V.
In 1993 she was awarded the prestigious Heisenberg Career Development Award of the Deutsche Forschungsgemeinschaft. She received her specialization in Internal Medicine (1991) and Endocrinology (1994), and became Adjunct Professor at the Ludwig-Maximilians-University in Munich (1998).
From 2007 to 2009 she was Director of the Department of Endocrinology at the Klinikum Schwabing in Munich. In 2010 she was recruited to Helmholtz Munich and the Technische Universität München (TUM) as Chair (full professor W3) to establish the Institute of Diabetes Research.
Jointly with Helmholtz Munich and TUM she has built one of the most renowned Study Centers for Childhood Diabetes - Early Care and Prevention. She was Speaker of the German Competence Network Diabetes Mellitus, is Speaker of the Global Platform for the Prevention of Autoimmune Diabetes, and is one of the type 1 diabetes academy heads of the German Center for Diabetes Research DZD e.V. She is one of 7 international principal investigators of the NIH funded TEDDY Consortium, and is the German representative for the NIH funded TrialNet consortium.
She has organized the German Diabetes Congress as well as the Immunology and Diabetes Society Congress, and has successfully established a distinguished annual Symposium on type 1 diabetes in Germany that attracts the world’s leading scientists.
- Director, Institute of Diabetes Research, Helmholtz Munich, German Research Center for Environmental Health
- Full Professor (W3), Chair in Diabetes and Gestational Diabetes, Faculty of Medicine, Klinikum rechts der Isar, Technische Universität München
- CEO, Forschergruppe Diabetes e.V.
- Honorary Professor, Faculty of Medicine, Technische Universität Dresden
Fields of Work & Expertise
Type 1 DiabetesPathogenesisPrediction and early diagnosisPrevention gestational diabetes
Research Recognition & Leadership
Member of the Bavarian Academy of Sciences and Humanities
President of the Immunology of Diabetes Society
President of Annual Congress of the Immunology of Diabetes Society (IDS), Munich, Germany
Speaker and Principal Investigator of the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD)
Principal Investigator, INNODIA (EU-IMI)
Type 1 Diabetes Academy Head, German Center for Diabetes Research (DZD e.V.)
President of the Annual Congress of the German Diabetes Society (DDG), Berlin, Germany
Principal Investigator, TRIALNET Consortium
Speaker of Competence Network Diabetes Mellitus, Germany
Principal Investigator, TEDDY Consortium (The Environmental Determinants of Diabetes in the Young)
Honors and awards
2022 – Novo Nordisk EASD
2022 – Finalist Falling Walls Science Breakthroughs of the Year, Category Life Sciences
since 2022 – Member of the Bavarian Academy of Sciences and Humanities
2021 – George S. Eisenbarth Award, Immunology of Diabetes Society
2019 – Glucohead of the Herz- und Diabeteszentrum Nordrhein-Westfalen
2018 – George Eisenbarth Award for Type 1 Diabetes Prevention, JDRF
2018 – Werner-Creutzfeldt-Award of the German Diabetes Association
2014 – Brownlee Lecture Award, Joslin Diabetes Center Boston
2013 – Mary Tyler Moore and S. Robert Levine Excellence in Clinical Research Award, JDRF
1998 – Ernst-Friedrich-Pfeiffer Award of the German Diabetes Association
1994 – Dr. Bürger-Büsing-Award of the German Diabetes Union
1993 – 1996 – Heisenberg Career Development Award of the German Research Association
1992 – Ferdinand-Bertram-Award of the German Diabetes Association
1988 – 1989 – Postdoctoral Fellowship Award of the German Research Association
Selected PublicationsSee all
Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children.